{
  "buildId": "5lGULuFSFhUrfWgBpMJq_",
  "gssp": true,
  "isFallback": false,
  "page": "/calc/[...slug]",
  "props": {
    "__N_SSP": true,
    "pageProps": {
      "calc": {
        "before_use": "",
        "calc_type": "calculator",
        "chief_complaint_en": [
          "Chest Pain",
          "Shortness of Breath"
        ],
        "cmeEndDate": "2025-07-25 00:00:00+00+67",
        "cmeLastReviewed": "2022-07-25 00:00:00+00+67",
        "cmeReleaseDate": "2020-10-08 00:00:00+00+00",
        "cmeVersion": "3918.1",
        "cme_status": "enabled",
        "content": {
          "about": {
            "evidence_based_medicine_en": "<p>The Hestia Criteria were first derived by Zondag et al in 2011 and have been validated in multiple additional studies.</p> <p><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21645235\" target=\"_blank\">Zondag 2011</a>:</p> <ul> <li>Patients with PE selected for outpatient treatment with predefined criteria can be treated with anticoagulants on an outpatient basis.</li> <li>VTE recurred in 2% of patients, with the upper limit of the confidence interval (CI) reaching 4.3%, which is lower than the predefined limit of 7%. None of the recurrences was fatal.</li> <li>None of the patients experienced a recurrent VTE event within seven days of the initial event, a period that equals the average duration of hospital admission for PE.</li> </ul> <p><a href=\"http://onlinelibrary.wiley.com/doi/10.1111/jth.12146/full\" target=\"_blank\">Zondag 2013</a>, “Hestia Criteria can safely select patients with pulmonary embolism for outpatient treatment irrespective of right ventricular function”:</p> <ul> <li>Study including 496 patients, found sensitivity 82% (95% CI 0.52–0.95) and specificity of 56% (95% CI 0.52–0.61).</li> <li>A 3-month follow-up period revealed a mortality rate of approximately 1%, although no deaths were caused by PE. Recurrent VTE occurred in 2.0% of the outpatient treatment group. Major bleeding occurred in &lt;1% of patients.</li> <li>The Hestia Criteria have a greater predictive value of adverse clinical outcome when compared to the <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/18757870\" target=\"_blank\">European Society of Cardiology guidelines</a> (which use biomarkers and echocardiography).</li> <li>Results suggest that a proportion of patients with right ventricular (RV) dysfunction who could be treated at home safely can be pre-identified. Clinical criteria, such as the Hestia Criteria, could be helpful in selecting patients with RV dysfunction who have a very low risk of an adverse clinical outcome and could be candidates for outpatient treatment.</li> </ul> <p><a href=\"https://em.osumc.edu/education/journalClub/PESIvsHESTIAforoutptPE2012.pdf\" target=\"_blank\">Zondag 2013</a>, “Comparison of two methods for selection of out of hospital treatment in patient with acute pulmonary embolism”:</p> <ul> <li>This study suggests that a proportion of patients classified as high risk by <calculator id=\"1247\"><abbr title=\"Simplified Pulmonary Embolism Severity Index\">sPESI</abbr></calculator> for reasons such as malignant disease, cardiopulmonary comorbidities or old age, can be safely treated at home when the Hestia Criteria are applied.</li> <li>From 2008 to 2010, 468 patients with PE were triaged with the Hestia Criteria for outpatient treatment: 247 PE patients were treated at home and 221 were treated as inpatients.</li> <li>Of the 247 patients treated at home, 189 (77%) patients were classified as low risk according to sPESI and 58 patients (23%) as high risk.</li> <li>Both the Hestia Criteria and sPESI selected &gt;50% of patients as low risk, with good sensitivity and negative predictive values for 30-day mortality: 82% and 99% for the Hestia Criteria and 91% and 100% for sPESI, respectively.</li> <li>This study demonstrated that 1/4 of patients treated at home safely in the Hestia study would have been classified as high risk by the sPESI and therefore would not have been eligible for outpatient treatment according to sPESI.</li> </ul> <p><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/26113241\" target=\"_blank\">Beam 2015</a>: </p> <ul> <li>This study evaluated the use of rivaroxaban 15 mg by mouth twice daily for 21 days, followed by 20 mg once per day. Investigators used modified Hestia exclusion criteria* to identify patients at low risk for adverse outcome. In this cohort of 106 patients discharged with VTE, 28% had PE, 67% had DVT, and 5% had combined DVT and PE. No patients experienced a new VTE, while 3 patients experienced recurrent VTE after treatment discontinuation. No patients experienced major bleeding.</li> <li>These results suggest safety of oral rivaroxaban for the outpatient treatment of low-risk VTE.</li> </ul> <p><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/27030891\" target=\"_blank\">Den Exter 2016</a>:</p> <ul> <li>Among patients sent home on the basis of the Hestia clinical decision rule alone, the 3-month risk of recurrent VTE was 1.1% (95% CI: 0.2–3.2%). The upper limit of the CI was well within the predefined safety limit of 7%; hence, this study serves as an external validation of the Hestia clinical decision rule.</li> <li>This trial confirms that outpatient treatment of acute PE, selected on the basis of the Hestia clinical decision rule alone, is feasible and associated with low risk of adverse events.</li> </ul> <p><a href=\"http://journals.sagepub.com/doi/abs/10.1177/1076029616651147\" target=\"_blank\">Weeda 2016</a>:</p> <ul> <li>The Hestia Criteria have an acceptable predictive accuracy to identify patients with PE at low risk for in-hospital or 30-day mortality, and the sensitivity and <abbr title=\"negative predictive value\">NPV</abbr> of the Hestia Criteria remained high in advanced age patients and those concomitantly diagnosed with active cancer or cardiopulmonary disease. &nbsp;</li> <li>The Hestia Criteria had excellent sensitivity (100%, 95% CI 79.1–100%) and NPV (100%, 95% CI 87.7–100%) for predicting in-hospital and 30-day mortality, but low specificity.</li> <li>In hospital positive likelihood ratio = 1.36 (sensitivity 100%, specificity 26.7%).</li> <li>30-day mortality positive likelihood ratio = 1.38 (sensitivity 100%, specificity 27.5%)</li> </ul> <p>*Modified Hestia criteria used in Beam 2015:</p> <ol> <li>Systolic hypotension (&lt;100 mm Hg and no history of low BP at baseline).</li> <li>Contraindication to low molecular weight heparin or warfarin treatment: active bleeding or high‐risk postoperative status, creatinine clearance &lt;30 mL/min, history of heparin‐induced thrombocytopenia, or warfarin skin necrosis).</li> <li>Other medical condition requiring hospital treatment (e.g. sepsis, new or decompensated existing organ failure, intractable pain).</li> <li>Social condition requiring hospital treatment (e.g. homelessness with history of nonadherence to treatment, suspected neglect or abuse, untreated psychosis, severe alcohol or drug dependency).</li> <li>Coagulopathy, any INR &gt;1.7, or thrombocytopenia (platelet count &lt;50 × 10<sup>9</sup>/L).</li> <li>Pregnancy.</li> <li>Incarceration</li> </ol>",
            "formula_en": "<p>If ≥1 present, patient is not eligible for outpatient management by Hestia Criteria.</p> <div class=\"table-responsive\"> <table class=\"table table-bordered\"> <tbody> <tr> <td> <p><strong>Hestia Criteria</strong></p> </td> </tr> <tr> <td> <p>Hemodynamically unstable*</p> </td> </tr> <tr> <td> <p>Thrombolysis or embolectomy needed</p> </td> </tr> <tr> <td> <p>Active bleeding or high risk for bleeding**</p> </td> </tr> <tr> <td> <p>&gt;24 hrs on supplemental oxygen required to maintain SaO<sub>2</sub> &gt;90% </p> </td> </tr> <tr> <td> <p>PE diagnosed while on anticoagulation</p> </td> </tr> <tr> <td> <p>Severe pain needing IV pain medication required &gt;24 hr</p> </td> </tr> <tr> <td> <p>Medical or social reason for admission &gt;24 hr (infection, malignancy, no support system)</p> </td> </tr> <tr> <td> <p>Creatinine clearance &lt;30 mL/min by Cockcroft-Gault formula</p> </td> </tr> <tr> <td> <p>Severe liver impairment***</p> </td> </tr> <tr> <td> <p>Pregnant</p> </td> </tr> <tr> <td> <p>Documented history of heparin-induced thrombocytopenia (HIT)</p> </td> </tr> </tbody> </table> </div> <p><br>*sBP &lt;100 mmHg and HR &gt;100, needing ICU care, or by clinician judgment. </p> <p>**GI bleeding or surgery within 2 weeks, stroke within 1 month, bleeding disorder or thrombocytopenia (platelet count &lt;75 × 10<sup>9</sup>/L), uncontrolled HTN (sBP &gt;180 or dBP &gt;110), or by clinician judgment.</p> <p>***By clinician judgment.</p>",
            "more_info_en": "<p>&nbsp;</p> <table> <tbody> <tr> <td> <p><strong>Hestia Criteria</strong></p> </td> <td> <p><strong>Risk</strong></p> </td> </tr> <tr> <td> <p>0 points</p> </td> <td> <p>Low (0% mortality, 2% VTE recurrence)</p> </td> </tr> <tr> <td> <p>&gt;0 points</p> </td> <td> <p>Not low</p> </td> </tr> </tbody> </table>",
            "references_list": {
              "Clinical Practice Guidelines": [
                {
                  "href": "https://www.ncbi.nlm.nih.gov/pubmed/18757870",
                  "text": "Torbicki A, Perrier A, Konstantinides S, et al. Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J. 2008;29(18):2276-315."
                }
              ],
              "Manufacturer Website": [],
              "Original/Primary Reference": [
                {
                  "href": "http://www.ncbi.nlm.nih.gov/pubmed/21645235",
                  "text": "Zondag W, Mos IC, Creemers-schild D, et al. Outpatient treatment in patients with acute pulmonary embolism: the Hestia Study. J Thromb Haemost. 2011;9(8):1500-7."
                }
              ],
              "Other References": [
                {
                  "href": "https://em.osumc.edu/education/journalClub/PESIvsHESTIAforoutptPE2012.pdf",
                  "text": "Zondag W, Den exter PL, Crobach MJ, et al. Comparison of two methods for selection of out of hospital treatment in patients with acute pulmonary embolism. Thromb Haemost. 2013;109(1):47-52."
                },
                {
                  "href": "https://www.ncbi.nlm.nih.gov/pubmed/20230418",
                  "text": "Agterof MJ, Schutgens RE, Snijder RJ, et al. Out of hospital treatment of acute pulmonary embolism in patients with a low NT-proBNP level. J Thromb Haemost. 2010;8(6):1235-41."
                }
              ],
              "Outcomes": [],
              "Validation": [
                {
                  "href": "http://onlinelibrary.wiley.com/doi/10.1111/jth.12146/full",
                  "text": "Zondag W, Vingerhoets LM, Durian MF, et al. Hestia criteria can safely select patients with pulmonary embolism for outpatient treatment irrespective of right ventricular function. J Thromb Haemost. 2013;11(4):686-92."
                },
                {
                  "href": "https://www.ncbi.nlm.nih.gov/pubmed/26113241",
                  "text": "Beam DM, Kahler ZP, Kline JA. Immediate discharge and home treatment with rivaroxaban of low risk venous thromboembolism diagnosed in two U.S. emergency departments: a one-year preplanned analysis. Acad Emerg Med 2015;22:789–95."
                },
                {
                  "href": "https://www.ncbi.nlm.nih.gov/pubmed/27030891",
                  "text": "Den Exter PL, Zondag W, Klok FA, et al. Efficacy and Safety of Outpatient Treatment Based on the Hestia Clinical Decision Rule with or without N-Terminal Pro-Brain Natriuretic Peptide Testing in Patients with Acute Pulmonary Embolism. A Randomized Clinical Trial. Am J Respir Crit Care Med. 2016;194(8):998-1006."
                },
                {
                  "href": "http://journals.sagepub.com/doi/abs/10.1177/1076029616651147 ",
                  "text": "Weeda ER, Kohn CG, Peacock WF, et al. External Validation of the Hestia Criteria for Identifying Acute Pulmonary Embolism Patients at Low Risk of Early Mortality. Clin Appl Thromb Hemost. 2016;:1076029616651147."
                }
              ],
              "Validations": []
            }
          },
          "contributor": {
            "expert_name": [
              "Daniel McFarland, MD"
            ]
          },
          "creator": [
            {
              "approved": false,
              "name": "Dr. Menno Huisman",
              "qa_en": ""
            }
          ],
          "how_to_use": {
            "pearls_pitfalls_en": "<ul> <li>Acute PE is associated with potentially life-threatening complications in the short term; therefore, careful risk stratification must be used when attempting to identify candidates for outpatient management.</li> </ul> <ul> <li>Not all patients deemed low-risk will have acute life threatening complications, and not all necessitate inpatient management. This tool only helps identify those who are low risk, and does not necessarily predict those who are high risk.</li> </ul>",
            "use_case_en": "<p>Hemodynamically stable patients with acute PE.</p>",
            "why_use_en": "<ul> <li>Safely triages patients for outpatient management.</li> <li>Easily applied in a clinical setting at the bedside.</li> <li>Associated with decreased length of stay and lower costs.</li> <li>Associated with fewer in-hospital complications.</li> </ul>"
          },
          "next_steps": {
            "advice_en": "<p>Patients identified as candidates for outpatient management:</p> <ul> <li>Must be counseled about risks of outpatient treatment and should be given close return precautions.</li> <li>Should remain in the hospital if there is any evidence of hemodynamic instability.</li> <li>Should be counseled on risks of bleeding once started on novel oral anticoagulant (NOAC) therapy.</li> </ul>",
            "critical_actions_en": "<ul> <li>Does <strong><em>not</em></strong> apply in patients with hemodynamic instability or those not being considered for outpatient management.</li> <li>If the patient is being considered for outpatient management, this tool may be used to help justify avoiding inpatient hospitalization.</li> <li>No decision rule should trump clinical gestalt.</li> </ul>",
            "management_en": "<ul> <li>Most hospitals have particular DVT/PE order sets or guidelines for management.</li> <li>Management typically includes the following:</li> <ul> <li>Heparin drip or enoxaparin with bridging to warfarin.</li> <li>Serial <abbr title=\"prothrombin time\">PT</abbr>/<abbr title=\"partial thromboplastin time\">PTT</abbr>.</li> <li>Telemetry and monitoring.</li> </ul> <li>Alternative:</li> <ul> <li>Treatment with a <abbr title=\"Novel oral anticoagulant\">NOAC</abbr>.</li> </ul> </ul>"
          },
          "related_resources": {
            "guidelines": [],
            "interests": [],
            "mdcalc_rating": [],
            "partner_contact": [],
            "sdm_tool": [],
            "teaching": [],
            "videos": []
          },
          "reviewer": []
        },
        "disease_en": [
          "Deep Venous Thrombosis",
          "Pulmonary Embolism"
        ],
        "dosing": false,
        "equation_logic": "4802a3a3c1b0d389592c0aa9f13e765d",
        "equation_logic_text": "var calc_output = [];\n\nvar u = parseFloat(unstable) + parseFloat(thrombolysis) + parseFloat(activebleeding) + parseFloat(oxygen) + parseFloat(anticoagulant) + parseFloat(painmeds) + parseFloat(medicalsocial) + parseFloat(crcl) + parseFloat(liver) + parseFloat(preg) + parseFloat(hit);\nvar msg, mini_msg, risk;\nif (u < 1) { mini_msg = \"Outpatient treatment\";\n    msg = \"Patient eligible for outpatient treatment (0% mortality, 2% VTE recurrence).\";\n    risk = 'Low'\n} else { mini_msg = \"Inpatient treatment\";\n    msg = \"Patient <u>not</u> eligible for outpatient treatment per the Hestia Criteria, which recommends admission and inpatient treatment.\";\n    risk = 'Not low'\n}\n\ncalc_output.push({\n    name: 'mini',\n    value: u,\n    value_text: 'points',\n    message: mini_msg\n});\ncalc_output.push({\n    name: 'hestia',\n    value: u,\n    value_text: 'points',\n    message: 'Hestia Criteria'\n});\ncalc_output.push({\n    name: 'risk',\n    value: risk,\n    value_text: 'risk',\n    message: msg\n});",
        "favorite_id": 3918,
        "full_title_en": "Hestia Criteria for Outpatient Pulmonary Embolism Treatment",
        "input_schema": [
          {
            "conditionality": "",
            "default": 0,
            "label_en": "Hemodynamically unstable",
            "name": "unstable",
            "optional": false,
            "options": [
              {
                "label": "No",
                "value": 0
              },
              {
                "label": "Yes",
                "value": 1
              }
            ],
            "show_points": true,
            "tips_en": "sBP <100 mmHg and HR >100, needing ICU care, or by clinician judgment",
            "type": "toggle"
          },
          {
            "conditionality": "",
            "default": 0,
            "label_en": "Thrombolysis or embolectomy needed",
            "name": "thrombolysis",
            "optional": false,
            "options": [
              {
                "label": "No",
                "value": 0
              },
              {
                "label": "Yes",
                "value": 1
              }
            ],
            "show_points": true,
            "tips_en": "For reasons other than hemodynamic instability",
            "type": "toggle"
          },
          {
            "conditionality": "",
            "default": 0,
            "label_en": "Active bleeding or high risk for bleeding",
            "name": "activebleeding",
            "optional": false,
            "options": [
              {
                "label": "No",
                "value": 0
              },
              {
                "label": "Yes",
                "value": 1
              }
            ],
            "show_points": true,
            "tips_en": "GI bleeding or surgery ≤2 weeks ago, stroke ≤1 month ago, bleeding disorder or platelet count <75 × 10⁹/L, uncontrolled HTN (sBP >180 or dBP >110), or by clinician judgment",
            "type": "toggle"
          },
          {
            "conditionality": "",
            "default": 0,
            "label_en": ">24 hrs on supplemental oxygen required to maintain SaO₂ >90%",
            "name": "oxygen",
            "optional": false,
            "options": [
              {
                "label": "No",
                "value": 0
              },
              {
                "label": "Yes",
                "value": 1
              }
            ],
            "show_points": true,
            "tips_en": "",
            "type": "toggle"
          },
          {
            "conditionality": "",
            "default": 0,
            "label_en": "PE diagnosed while on anticoagulation",
            "name": "anticoagulant",
            "optional": false,
            "options": [
              {
                "label": "No",
                "value": 0
              },
              {
                "label": "Yes",
                "value": 1
              }
            ],
            "show_points": true,
            "tips_en": "",
            "type": "toggle"
          },
          {
            "conditionality": "",
            "default": 0,
            "label_en": "Severe pain needing IV pain medication required >24 hr",
            "name": "painmeds",
            "optional": false,
            "options": [
              {
                "label": "No",
                "value": 0
              },
              {
                "label": "Yes",
                "value": 1
              }
            ],
            "show_points": true,
            "tips_en": "",
            "type": "toggle"
          },
          {
            "conditionality": "",
            "default": 0,
            "label_en": "Medical or social reason for admission >24 hr (infection, malignancy, no support system)",
            "name": "medicalsocial",
            "optional": false,
            "options": [
              {
                "label": "No",
                "value": 0
              },
              {
                "label": "Yes",
                "value": 1
              }
            ],
            "show_points": true,
            "tips_en": "",
            "type": "toggle"
          },
          {
            "conditionality": "",
            "default": 0,
            "label_en": "Creatinine clearance <30 mL/min by <calculator id='43'>Cockcroft-Gault</calculator>",
            "name": "crcl",
            "optional": false,
            "options": [
              {
                "label": "No",
                "value": 0
              },
              {
                "label": "Yes",
                "value": 1
              }
            ],
            "show_points": true,
            "tips_en": "",
            "type": "toggle"
          },
          {
            "conditionality": "",
            "default": 0,
            "label_en": "Severe liver impairment",
            "name": "liver",
            "optional": false,
            "options": [
              {
                "label": "No",
                "value": 0
              },
              {
                "label": "Yes",
                "value": 1
              }
            ],
            "show_points": true,
            "tips_en": "By clinician judgment",
            "type": "toggle"
          },
          {
            "conditionality": "",
            "default": 0,
            "label_en": "Pregnant",
            "name": "preg",
            "optional": false,
            "options": [
              {
                "label": "No",
                "value": 0
              },
              {
                "label": "Yes",
                "value": 1
              }
            ],
            "show_points": true,
            "tips_en": "",
            "type": "toggle"
          },
          {
            "conditionality": "",
            "default": 0,
            "label_en": "Documented history of heparin-induced thrombocytopenia (HIT)",
            "name": "hit",
            "optional": false,
            "options": [
              {
                "label": "No",
                "value": 0
              },
              {
                "label": "Yes",
                "value": 1
              }
            ],
            "show_points": true,
            "tips_en": "",
            "type": "toggle"
          }
        ],
        "instructions_en": "<p>Use in hemodynamically stable patients with acute pulmonary embolism (PE).</p>",
        "logic_language": "javascript",
        "md5": "86fe2049be55f538284c4be0478378de",
        "medium_description_en": "<p>Identifies low-risk PE patients safe for outpatient treatment.</p>",
        "purpose_en": [
          "Prognosis",
          "Treatment"
        ],
        "search_abbreviation_en": [
          "VTE",
          "DVT",
          "PE",
          "hestia",
          "outpt",
          "outpatient",
          "tx",
          "treatment",
          "clot",
          "venous thromboembolism",
          "pulmonary embolism",
          "pulmonary embolus"
        ],
        "search_id": "c-3918",
        "seo": {
          "keywords_en": "VTE, DVT, PE, hestia, outpt, outpatient, tx, treatment, clot",
          "meta_description_en": "The Hestia Criteria for VTE evaluates a patient for recurrent VTE and suitability for outpatient treatment."
        },
        "short_description_en": "Outpatient VTE treatment.",
        "short_title_en": "Hestia Criteria",
        "slug": "hestia-criteria-outpatient-pulmonary-embolism-treatment",
        "specialty_en": [
          "Cardiology",
          "Critical Care",
          "Emergency Medicine",
          "Hematology and Oncology",
          "Internal Medicine",
          "Pulmonology",
          "Surgery (Cardiothoracic)",
          "Surgery (Vascular)"
        ],
        "system_en": [
          "Respiratory"
        ]
      },
      "contributors": [
        {
          "contributors_page": false,
          "description": "",
          "firstName": "Daniel",
          "hasDisclosure": [],
          "img": "",
          "lastName": "McFarland",
          "name": "Daniel McFarland, MD",
          "signedCOI": true,
          "status": "",
          "target": ""
        }
      ],
      "creators": [
        {
          "about_en": "<p>Menno Huisman, MD, PhD, FESC, is a professor of medicine in the department of medicine - thrombosis and hemostasis at Leiden University Medical Center in The Netherlands. He is an internist with specialty in cardiovascular medicine. Dr. Huisman’s primary research is focused on the clinical diagnosis and treatment of venous and arterial thromboembolic disorders.</p>",
          "deceased": false,
          "description": "",
          "firstName": "",
          "img": "",
          "lastName": "",
          "name": "Dr. Menno Huisman",
          "photo_en": "https://cdn-web-img.mdcalc.com/people/Dr-Menno-Huisman.jpg",
          "pubmedLink": "https://pubmed.ncbi.nlm.nih.gov/?term=Huisman+MV+%5Bauthor%5D",
          "signedCOI": false
        }
      ],
      "envs": {
        "CANONICAL_URL_ROOT": "https://www.mdcalc.com",
        "CONTENT_SERVER_TAG": "WEB_PROD",
        "RECAPTCHA_PUBLIC_KEY": "6Lcu1mMkAAAAAAwmSDO3I7JNaUo9YtZ3jnrzTP6a",
        "STRIPE_PUB_KEY": "pk_live_yYm2UzDzaudhFgqWcKbv9vH7"
      },
      "faqs": [
        {
          "cme_faq": {
            "answer": "<p>MDCalc&rsquo;s Continuing Medical Education (CME) service allows users to easily earn AMA PRA Category 1 CreditsTM through regular use of MDCalc. Simply put, on top of getting the best medical calculators in the world, your usage will help you achieve your annual CME requirements, including specialty CME, without any extra effort.</p>",
            "question": "What is MDCalc CME?",
            "type": "Using"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>Yes, in support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and MDCalc Ltd. Inc. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.</p>",
            "question": "Is MDCalc CME accredited?",
            "type": "Using"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>Only United States attending physicians, nurse practitioners, nurses, and physician assistants are eligible for our CME service.</p>",
            "question": "Who can enroll and how?",
            "type": "Using"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>We have over 275 CME-eligible calculators across various specialties. You can read the clinical content supporting any CME calculators to start earning. Once you have viewed all the supporting content for a calculator, you will have officially earned the credit amount (0.5 credits) and will be able to redeem a certificate. For now, only calc content in CME-eligible calcs is eligible for CME credits, however, we&rsquo;ll be expanding our CME service to include more of our content in the future.</p>",
            "question": "What activities can I do to earn CME credits?",
            "type": "Using"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>Simply use our search bar or visit our homepage to easily find CME-eligible calcs. You must be enrolled in our CME service to see which calcs are CME-eligible.</p>",
            "question": "Where can I find calcs with which I can earn credits?",
            "type": "Using"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>Once you&rsquo;ve enrolled in our CME service, you will have a personal CME Dashboard where you can view all of your earned credits. You can navigate to the dashboard by clicking the CME button in the header at the top of any page.</p>",
            "question": "Where can I see which credits I’ve earned?",
            "type": "Using"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>Go to your CME Dashboard and select the credits you&rsquo;d like to redeem, fill out a few dropdown answers about how you used the calc, and then proceed to checkout.</p>",
            "question": "How do I redeem CME credits?",
            "type": "Using"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>No. Earning credits as you use calcs is free, but either you (or your employer) will need to purchase an annual subscription to redeem your CME certificates.</p>",
            "question": "Are CME credits free?",
            "type": "Using"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>Just like with earned credits, you can view your CME certificates on your CME Dashboard in the &ldquo;CME Certificates&rdquo; tab. Certificates include a list of all of the calcs for which CME was earned along with a tally of the specialty CME.</p>",
            "question": "Where can I see my CME certificates?",
            "type": "Using"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>One year from the date of purchase.</p>",
            "question": "How long do credits in an annual subscription last?",
            "type": "Purchasing"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>General; Addiction and Controlled Substances; Cardiac Care; Domestic and Intimate Partner Violence; Geriatrics; HIV and Infectious Disease; Hospice, End-of-Life, Terminal Illness, and Palliative Care; Mental and Behavioral Health; Pain Management; Pediatrics; Stroke; and Trauma.</p>",
            "question": "What specialty CME credits are included in the plan?",
            "type": "Purchasing"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>Your gift card will be sent via email within 1-2 business days of making your purchase. You will be able to select from the following options - Visa, Amazon.com, Apple. Be sure to claim your gift card offer within 90 days of receiving the email.</p>\n<p>Your CME purchase may have implications for tax reporting purposes. The cost of your CME product may or may not be tax-deductible when used for professional purposes. Any reimbursed amount for incentives must be declared as personal income for tax purposes. Please consult your tax advisor. MDCalc does not provide tax advice.</p>",
            "question": "I ordered a CME package with a gift card. How does it work?",
            "type": "Purchasing"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>Per the new guidelines from ACCME, the receipt will separate the cost you paid into the cost of the gift card and the cost of the CME learning activity.</p>",
            "question": "What will show on my receipt for CME when it includes a gift card?",
            "type": "Purchasing"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>You can get a refund (minus any promotional gift amount) within 30-days if the ease of earning and redeeming does not meet your expectations and if you have redeemed no more than 4 credits. Please email <a href=\"mailto:team@mdcalc.com\" target=\"_blank\" rel=\"noopener\">team@mdcalc.com</a> to request a refund.</p>",
            "question": "How do I get a refund if I'm not satisfied?",
            "type": "Purchasing"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>You can upgrade your subscription throughout your billing cycle and pay the difference for a higher plan. You may request to downgrade your plan to a lower level to coincide with your next renewal. Please email <a href=\"mailto:team@mdcalc.com\" target=\"_blank\" rel=\"noopener\">team@mdcalc.com</a> to request changes.</p>",
            "question": "How do I later upgrade to a different plan if I need more credits?",
            "type": "Purchasing"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>Gift card plans are available for 1 year and do not auto-renew. Standard, non gift-card subscriptions are auto-renewed annually. You can disable the automatic renewal of your subscription at any time by emailing <a href=\"mailto:team@mdcalc.com\" target=\"_blank\" rel=\"noopener\">team@mdcalc.com</a>.</p>",
            "question": "Do CME plans auto-renew?",
            "type": "Purchasing"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>If you&rsquo;re part of a team or practice that wants to sign up five or more physicians, please email us at <a href=\"mailto:team@mdcalc.com\" target=\"_blank\" rel=\"noopener\">team@mdcalc.com</a> for more information.</p>",
            "question": "How do I get information on a discounted bulk subscription program for my institution, team, or practice?",
            "type": "Purchasing"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>On July 28, 2022, ACCME updated the guidelines regarding the use of high-value incentives. These guidelines allow for the use of gift card rewards in a regulated manner. Visit the ACCME website to read their guidelines.</p>",
            "question": "Did the ACCME decide to regulate gift cards?",
            "type": "Purchasing"
          }
        }
      ],
      "headConfig": {
        "canonicalUrl": "/calc/3918/hestia-criteria-outpatient-pulmonary-embolism-treatment",
        "description": "The Hestia Criteria for VTE evaluates a patient for recurrent VTE and suitability for outpatient treatment.",
        "keywords": "VTE, DVT, PE, hestia, outpt, outpatient, tx, treatment, clot",
        "title": "Hestia Criteria for Outpatient Pulmonary Embolism Treatment"
      },
      "isCMECalc": true,
      "measurements": [],
      "relCalcs": [
        {
          "calcId": 1247,
          "short_title_en": "Simplified PESI",
          "slug": "simplified-pesi-pulmonary-embolism-severity-index"
        },
        {
          "calcId": 10465,
          "short_title_en": "IMPROVE Bleeding Risk Score",
          "slug": "improve-bleeding-risk-score"
        },
        {
          "calcId": 10138,
          "short_title_en": "Age-Adjusted D-dimer",
          "slug": "age-adjusted-d-dimer-venous-thromboembolism-vte"
        }
      ],
      "societies": {
        "American Association for the Study of Liver Diseases": {
          "abbreviation": "AASLD",
          "description": "plain-text",
          "img": "https://s3-us-west-2.amazonaws.com/cdn-web-img.mdcalc.com/logo/other_society.png",
          "web_link": "https://www.aasld.org/"
        },
        "American College Of Emergency Physicians": {
          "abbreviation": "ACEP",
          "description": "plain-text",
          "img": "https://s3-us-west-2.amazonaws.com/apps.mdcalc.com/images/american-college-of-emergency-physicians-squarelogo.png",
          "web_link": "https://www.acep.org/"
        },
        "American College of Gastroenterology": {
          "abbreviation": "ACG",
          "description": "plain-text",
          "img": "https://s3-us-west-2.amazonaws.com/cdn-web-img.mdcalc.com/logo/acg_logo.png",
          "web_link": "https://gi.org/"
        },
        "American College of Rheumatology": {
          "abbreviation": "ACR",
          "description": "plain-text",
          "img": "https://s3-us-west-2.amazonaws.com/cdn-web-img.mdcalc.com/logo/other_society.png",
          "web_link": "https://www.rheumatology.org/"
        },
        "American Gastroenterological Association": {
          "abbreviation": "AGA",
          "description": "plain-text",
          "img": "https://apps.mdcalc.com/images/societies/aga.jpeg",
          "web_link": "https://gastro.org"
        },
        "American Heart Association": {
          "abbreviation": "AHA",
          "description": "plain-text",
          "img": "https://s3-us-west-2.amazonaws.com/apps.mdcalc.com/images/societies/+AHA+(American+Heart+Association).png",
          "target": "aha",
          "web_link": "http://www.heart.org/HEARTORG/"
        },
        "American Urological Association": {
          "abbreviation": "AUA",
          "description": "plain-text",
          "img": "https://s3-us-west-2.amazonaws.com/cdn-web-img.mdcalc.com/logo/other_society.png",
          "web_link": "https://www.auanet.org/"
        },
        "EB Medicine": {
          "abbreviation": "EB Medicine",
          "description": "EB Medicine is the premier provider of evidence-based clinical content and CME resources for emergency medicine practitioners.",
          "img": "https://cdn-web-img.mdcalc.com/other/eb_medicine-icon-only.jpg",
          "target": "eb-medicine",
          "web_link": "http://www.ebmedicine.net/"
        },
        "MDCalc CME": {
          "abbreviation": "MDCalc CME",
          "img": "https://cdn-web-img.mdcalc.com/Stroke-CME-content.jpg",
          "web_link": "https://www.mdcalc.com/stroke-cme?utm_source=NIHSS_calc&utm_medium=NIHSS_calc&utm_campaign=NIHSS_calc"
        },
        "OTHER": {
          "abbreviation": "OTHER"
        },
        "Postgraduate Institute for Medicine": {
          "abbreviation": "PIM",
          "description": "plain-text",
          "img": "https://cdn-web-img.mdcalc.com/PIM-circle-COLOR.jpeg",
          "target": "pim",
          "web_link": "https://www.pimed.com/"
        },
        "VACO Podcast": {
          "description": "Listen to the VACO co-creators break down how to use VACO\\, what it does\\, and what it doesn’t.",
          "img": "https://cdn-web-img.mdcalc.com/content/podcast 2.png",
          "web_link": "https://www.stimuluspodcast.com/post/32-the-covid-mortality-score-vaco"
        }
      },
      "validSections": [
        "whenToUseViewed",
        "pearlsPitfallsViewed",
        "whyUseViewed",
        "nextStepsViewed",
        "evidenceViewed"
      ]
    }
  },
  "query": {
    "slug": [
      "3918",
      "hestia-criteria-outpatient-pulmonary-embolism-treatment"
    ]
  },
  "scriptLoader": []
}